Format

Send to

Choose Destination
J Cancer Res Ther. 2019;15(2):370-374. doi: 10.4103/jcrt.JCRT_299_18.

Computed tomography-guided percutaneous cryoablation for lung ground-glass opacity: A pilot study.

Author information

1
Department of Oncology, First Affiliated Hospital of Jinan University; Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou, China.
2
Department of Oncology, First Affiliated Hospital of Jinan University, Guangzhou, China.
3
Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou, China.

Abstract

Context:

Ground-glass opacity (GGO) is a nonspecific imaging parameter for early-stage pulmonary cancer. In these cases, a definite diagnosis and prompt surgery usually yield satisfactory outcomes.

Aims:

This study aimed to assess the safety and feasibility of cryoablation treatment for lung GGO.

Subjects and Methods:

We reviewed the clinical data of 14 patients (19 lung tumors) with lung GGO and evaluated the adverse events, lung function, and treatment efficacy after cryoablation.

Statistical Analysis Used:

Statistical analyses were performed using the Statistical Package for the Social Sciences software (version 13.0; SPSS Inc., Chicago, IL, USA).

Results:

None of the patients exhibited serious complications, and lung function recovered to >95% after 1 month. During a follow-up, computed tomography scan at 24 months, the GGO appeared to have been successfully ablated in all patients.

Conclusion:

Cryoablation may serve as a safe and feasible option for the treatment of GGO.

KEYWORDS:

Ablation; cryoablation; ground-glass opacity

PMID:
30964113
DOI:
10.4103/jcrt.JCRT_299_18
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center